No photo of David P Richman

View Scopus Profile

David P Richman, MD

Professor

  • 3584 Citations
  • 31 h-Index
1969 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David P Richman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Antigen-specific treatment of myasthenia gravis: Chimeric autoantibody receptor T cells targeting autoimmune B cells

Richman, D. P.

Project: Research project

Development of Animal Models of Anti-MuSK Myasthenia

Richman, D. P.

National Institutes of Health

9/30/10 → 8/31/13

Project: Research project

    • IX INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS

    Richman, D. P.

    National Institutes of Health

    5/1/97 → 4/30/98

    Project: Research project

    • STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES

    Fairclough, R. H., Richman, D. P., Nelson, D., Martinez-Carrion, M. & Kezdy, F.

    National Institutes of Health

    1/1/87 → 9/30/92

    Project: Research project

    • PATHOGENIC MECHANISMS IN MYASTHENIA

    Richman, D. P.

    National Institutes of Health

    7/1/84 → 6/30/97

    Project: Research project

    • Research Output

    Muscle-Specific Kinase Myasthenia Gravis

    Borges, L. S. & Richman, D. P., May 8 2020, In : Frontiers in immunology. 11, 707.

    Research output: Contribution to journal › Review article

    Open Access

    • Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma

    Lara, M. S., Afify, A. M., Ellis, M. P., Phan, C., Richman, D. P. & Riess, J., Jan 1 2019, In : Clinical lung cancer.

    Research output: Contribution to journal › Article

    1 Scopus citations

    Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia

    on behalf of the DAPPER Study Team, Jan 1 2019, In : Muscle and Nerve. 60, 3, p. 292-298 7 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia

    Sanders, D. B., Juel, V. C., Harati, Y., Smith, A. G., Peltier, A. C., Marburger, T., Lou, J. S., Pascuzzi, R. M., Richman, D. P., Xie, T., Demmel, V., Jacobus, L. R., Aleš, K. L. & Jacobus, D. P., Jan 1 2018, (Accepted/In press) In : Muscle and Nerve.

    Research output: Contribution to journal › Article

    • 12 Scopus citations

    Developing treatment guidelines for myasthenia gravis

    The MGFA Task Force On Mg Treatment Guidance, Jan 1 2018, In : Annals of the New York Academy of Sciences. 1412, 1, p. 95-101 7 p.

    Research output: Contribution to journal › Review article

    • 10 Scopus citations